COVID-19 Project Team: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 91: | Line 91: | ||
* [[User:Zaida Obeidat|Zaida Obeidat, M.D.]] | * [[User:Zaida Obeidat|Zaida Obeidat, M.D.]] | ||
* [[User:Syed rizvi|Syed Rizvi, M.B.B.S.]] | * [[User:Syed rizvi|Syed Rizvi, M.B.B.S.]] | ||
'''[[COVID-19 medical therapy]] | '''[[COVID-19 medical therapy]] | ||
* [[User:Sara Zand|Sara Zand, M.D.]] | * [[User:Sara Zand|Sara Zand, M.D.]] | ||
'''[[COVID-19 other diagnostic studies]] | '''[[COVID-19 other diagnostic studies]] | ||
* [[User:Mandana Safakhah|Mandana Safakhah, M.D.]] | * [[User:Mandana Safakhah|Mandana Safakhah, M.D.]] |
Revision as of 21:56, 12 August 2020
COVID-19 Project |
---|
Introduction |
Team |
Meetings' Summary |
Topics |
Ongoing Clinical Trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Meet The Team
Associate Editor(s)-in-Chief:
- The name of the leaders are written in bold: